Mechanisms and funding opportunities in genitourinary cancer clinical research

    Research output: Contribution to journalArticle

    Abstract

    Progress in the prevention, diagnosis, and treatment of genitourinary cancers is dependent on well-conducted clinical trials. The complexity and cost of clinical research continues to escalate, and success is dependent on adequate funding. Opportunities to fund such research include federal, industry, and private sources. The mechanisms whereby larger trials are conducted include contract research organizations, publically- and privately funded consortia, and the National Clinical Trials Network of the National Cancer Institute. The National Clinical Trials Network is the prime venue for investigators to conduct independent, phase III trials in the United States.

    Original languageEnglish (US)
    JournalUrologic Oncology: Seminars and Original Investigations
    DOIs
    StateAccepted/In press - Jan 1 2018

    Fingerprint

    Urogenital Neoplasms
    Clinical Trials
    Research
    National Cancer Institute (U.S.)
    Financial Management
    Contracts
    Industry
    Research Personnel
    Organizations
    Costs and Cost Analysis

    Keywords

    • Clinical trials
    • Cooperative Groups
    • Funding
    • NCTN
    • Urologic cancers

    ASJC Scopus subject areas

    • Oncology
    • Urology

    Cite this

    @article{28c5d9ff3ad943808efacfbccaa8ec52,
    title = "Mechanisms and funding opportunities in genitourinary cancer clinical research",
    abstract = "Progress in the prevention, diagnosis, and treatment of genitourinary cancers is dependent on well-conducted clinical trials. The complexity and cost of clinical research continues to escalate, and success is dependent on adequate funding. Opportunities to fund such research include federal, industry, and private sources. The mechanisms whereby larger trials are conducted include contract research organizations, publically- and privately funded consortia, and the National Clinical Trials Network of the National Cancer Institute. The National Clinical Trials Network is the prime venue for investigators to conduct independent, phase III trials in the United States.",
    keywords = "Clinical trials, Cooperative Groups, Funding, NCTN, Urologic cancers",
    author = "Christopher Ryan",
    year = "2018",
    month = "1",
    day = "1",
    doi = "10.1016/j.urolonc.2018.05.024",
    language = "English (US)",
    journal = "Urologic Oncology: Seminars and Original Investigations",
    issn = "1078-1439",
    publisher = "Elsevier Inc.",

    }

    TY - JOUR

    T1 - Mechanisms and funding opportunities in genitourinary cancer clinical research

    AU - Ryan, Christopher

    PY - 2018/1/1

    Y1 - 2018/1/1

    N2 - Progress in the prevention, diagnosis, and treatment of genitourinary cancers is dependent on well-conducted clinical trials. The complexity and cost of clinical research continues to escalate, and success is dependent on adequate funding. Opportunities to fund such research include federal, industry, and private sources. The mechanisms whereby larger trials are conducted include contract research organizations, publically- and privately funded consortia, and the National Clinical Trials Network of the National Cancer Institute. The National Clinical Trials Network is the prime venue for investigators to conduct independent, phase III trials in the United States.

    AB - Progress in the prevention, diagnosis, and treatment of genitourinary cancers is dependent on well-conducted clinical trials. The complexity and cost of clinical research continues to escalate, and success is dependent on adequate funding. Opportunities to fund such research include federal, industry, and private sources. The mechanisms whereby larger trials are conducted include contract research organizations, publically- and privately funded consortia, and the National Clinical Trials Network of the National Cancer Institute. The National Clinical Trials Network is the prime venue for investigators to conduct independent, phase III trials in the United States.

    KW - Clinical trials

    KW - Cooperative Groups

    KW - Funding

    KW - NCTN

    KW - Urologic cancers

    UR - http://www.scopus.com/inward/record.url?scp=85050978284&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85050978284&partnerID=8YFLogxK

    U2 - 10.1016/j.urolonc.2018.05.024

    DO - 10.1016/j.urolonc.2018.05.024

    M3 - Article

    C2 - 30072304

    AN - SCOPUS:85050978284

    JO - Urologic Oncology: Seminars and Original Investigations

    JF - Urologic Oncology: Seminars and Original Investigations

    SN - 1078-1439

    ER -